Implementing Community Palliative Care for People With Heart Failure
Community palliative care program tested for heart failure patients
Plain English Summary
Palliative Care for People With HF is a Not Applicable clinical trial sponsored by Indiana University studying Congestive Heart Failure, Congestive Heart Failure(CHF), Congestive Heart Failure (CHF), Congestive Heart Failure Chronic. This study tests a program called ADAPT, designed to help people with heart failure manage their symptoms and improve their quality of life. It is for individuals diagnosed with Congestive Heart Failure (CHF) who are receiving outpatient care. Participation involves healthcare providers and staff learning how to implement the ADAPT program in their clinics. The alternative is standard heart failure care, which may not always include specialized symptom management and support. The trial aims to enroll 20 participants.
Official Summary
Imagine having heart failure, a condition where the heart struggles to pump blood, making daily life hard. People with heart failure often don't feel well and end up going to the hospital a lot. Many of these people could feel better with extra help, but there aren't many programs that offer support beyond usual heart failure treatments. That's where the ADAPT program comes in, which stands for "Advancing Symptom Alleviation with Palliative Treatment." In this program, nurses and social workers call people weekly, helping them manage their toughest symptoms, offering tools to cope with heart failure, and keeping the patients' current doctors involved. We tested this program in a research study with heart failure patients and found that it improved their quality of life and lowered depression, anxiety, and heart failure symptoms. The question now is if the ADAPT program will work in the community, outside of a research setting, so that more people could benefit from it. Specifically, can the ADAPT program work well in new places? Will patients and their families find it helpful? Most importantly, can it help improve the lives of people with heart failure in these new settings? To answer these questions, the study team will work with healthcare providers to 1) ask how to adjust the ADAPT program to work well in various settings (e.g. primary care, heart failure clinic) and 2) use this information to create simple materials and trainings to help them easily provide ADAPT. This will prepare for the next phase of this project to test out the new ADAPT program.
Who Can Participate
Here is what you need to know about eligibility for this trial. Healthcare professionals and leaders with at least 6 months of experience caring for heart failure patients can join. Participants must be 18 years or older. There are no specific health requirements for the healthcare professionals participating in this implementation study. This trial is studying Congestive Heart Failure, Congestive Heart Failure(CHF), Congestive Heart Failure (CHF), Congestive Heart Failure Chronic, so participants generally need a confirmed diagnosis. The trial is currently accepting new participants.
What They're Measuring
The primary outcome measures will help understand how well the ADAPT program can be put into practice in different healthcare settings, ultimately aiming to improve the daily lives of heart failure pa The specific primary outcome measures are: Qualitative Themes (Baseline). These endpoints are how researchers determine whether the treatment is effective and will form the basis of any future regulatory submissions.
About This Phase
This study does not have a traditional clinical phase designation. It may be an observational study that follows patients without intervening in their care, an expanded access or compassionate use program, or other non-interventional research. These studies contribute valuable data about disease progression, treatment patterns, and patient outcomes.
Why This Trial Matters
This trial matters because it aims to make a supportive care program widely available to heart failure patients in their communities, addressing a gap in comprehensive symptom management beyond typica This research targets Congestive Heart Failure, Congestive Heart Failure(CHF), Congestive Heart Failure (CHF), Congestive Heart Failure Chronic, where improved treatment options are needed.
Investor Insight
This observational study focuses on the implementation of a palliative care program, suggesting a need for better patient support in a large market of heart failure patients, with potential for future
Is This Trial Right for Me?
Ask your doctor if a palliative care program like ADAPT could help manage your heart failure symptoms. This study involves healthcare providers learning to deliver the ADAPT program, which includes regular check-ins and symptom management support for patients. The goal is to make the ADAPT program easier for clinics to use, so more patients can benefit from it. This trial is currently recruiting participants. The trial is being conducted at 1 site. Always discuss clinical trial participation with your healthcare provider before making any decisions. This information is for educational purposes only and is not medical advice.
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.
Study Design
- Study Type: OBSERVATIONAL
- Enrollment: 20 participants
Interventions
- OTHER: ADAPT — Concurrent mixed methods design with rapid qualitative analysis of data from semi-structured interviews, structured clinic observations, and descriptive analysis of surveys. Participants will include clinical providers (e.g. physicians, advanced practice providers, nurses, social workers), staff, and leadership at IU Health. As opposed to traditional qualitative methods, rapid qualitative approaches are commonly used in implementation-focused research to guide real-time implementation processes.
Primary Outcomes
- Qualitative Themes (Baseline)
Trial Locations
- IUHealth, Indianapolis, Indiana, United States
Frequently Asked Questions
What is clinical trial NCT07356843?
NCT07356843 is a Not Applicable OBSERVATIONAL study titled "Palliative Care for People With HF." It is currently recruiting and is sponsored by Indiana University. The trial targets enrollment of 20 participants.
What conditions does NCT07356843 study?
This trial investigates treatments for Congestive Heart Failure, Congestive Heart Failure(CHF), Congestive Heart Failure (CHF), Congestive Heart Failure Chronic. The primary condition under study is Congestive Heart Failure.
What treatments are being tested in NCT07356843?
The interventions being studied include: ADAPT (OTHER). Concurrent mixed methods design with rapid qualitative analysis of data from semi-structured interviews, structured clinic observations, and descriptive analysis of surveys. Participants will include clinical providers (e.g. physicians, advanced practice providers, nurses, social workers), staff, and leadership at IU Health. As opposed to traditional qualitative methods, rapid qualitative approaches are commonly used in implementation-focused research to guide real-time implementation processes.
What does Not Applicable mean for NCT07356843?
This study does not have a defined clinical phase. It may be an observational study, expanded access program, or other non-interventional research.
What is the current status of NCT07356843?
This trial is currently "Recruiting." It started on 2025-10-20. The estimated completion date is 2028-09.
Who is sponsoring NCT07356843?
NCT07356843 is sponsored by Indiana University. The sponsor is responsible for funding, designing, and overseeing the clinical trial.
How many people can participate in NCT07356843?
The trial aims to enroll 20 participants. The trial is currently recruiting and accepting new participants.
How is NCT07356843 designed?
This is a observational study.
What are the primary outcomes being measured in NCT07356843?
The primary outcome measures are: Qualitative Themes (Baseline). These are the main endpoints researchers use to determine whether the treatment is effective.
Where is NCT07356843 being conducted?
This trial is being conducted at 1 site, including Indianapolis, Indiana (United States).
Where can I find official information about NCT07356843?
The official record for NCT07356843 is available on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT07356843. This government database provides the most up-to-date and detailed information about the trial.
What is NCT07356843 testing in simple terms?
This study tests a program called ADAPT, designed to help people with heart failure manage their symptoms and improve their quality of life. It is for individuals diagnosed with Congestive Heart Failure (CHF) who are receiving outpatient care.
Why is this trial significant?
This trial matters because it aims to make a supportive care program widely available to heart failure patients in their communities, addressing a gap in comprehensive symptom management beyond typica
What are the potential risks of participating in NCT07356843?
As this is an implementation study for healthcare providers, direct risks to patients are minimal, but the effectiveness of the program in new settings is being evaluated. Potential challenges could include adapting the program to different clinic workflows or ensuring consistent delivery of care. As with any clinical trial, participants are closely monitored and can withdraw at any time.
Should I consider participating in NCT07356843?
Ask your doctor if a palliative care program like ADAPT could help manage your heart failure symptoms. This study involves healthcare providers learning to deliver the ADAPT program, which includes regular check-ins and symptom management support for patients. The goal is to make the ADAPT program easier for clinics to use, so more patients can benefit from it. Always discuss clinical trial participation with your healthcare provider to determine if it is appropriate for your specific situation.
What does NCT07356843 signal from an investment perspective?
This observational study focuses on the implementation of a palliative care program, suggesting a need for better patient support in a large market of heart failure patients, with potential for future This is a Not Applicable trial, which is in early development stages.
What happens if the treatment in this trial doesn't work?
Participation involves healthcare providers and staff learning how to implement the ADAPT program in their clinics. Participants in clinical trials always have the right to withdraw and pursue alternative treatments. The study team will help transition patients to other available options.
Related Conditions
More Congestive Heart Failure Trials
This analysis is AI-generated and does not constitute medical advice. Always consult your healthcare provider before making decisions about clinical trial participation.